{"id":"NCT03939533","sponsor":"Octapharma","briefTitle":"Study to Monitor Subcutaneous Human Immunoglobulin Administered at Modified Dosing Regimens in Patients With Primary Immunodeficiency Diseases","officialTitle":"Clinical Phase 3 Study to Monitor the Safety, Tolerability, and Efficacy of Subcutaneous Human Immunoglobulin (CUTAQUIG®) Administered at Modified Dosing Regimens in Patients With Primary Immunodeficiency Diseases","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2019-10-17","primaryCompletion":"2022-01-03","completion":"2022-01-03","firstPosted":"2019-05-06","resultsPosted":"2023-11-07","lastUpdate":"2023-11-07"},"enrollment":64,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Primary Immune Deficiency Disorder"],"interventions":[{"type":"DRUG","name":"CUTAQUIG","otherNames":[]}],"arms":[{"label":"Increased Volume Cohort - Cohort 1","type":"EXPERIMENTAL"},{"label":"Increased Infusion Rate Cohort - Cohort 2","type":"EXPERIMENTAL"},{"label":"Every Other Week Dosing Cohort - Cohort 3","type":"EXPERIMENTAL"}],"summary":"CLINICAL PHASE 3 STUDY TO MONITOR THE SAFETY, TOLERABILITY, AND EFFICACY OF SUBCUTANEOUS HUMAN IMMUNOGLOBULIN (CUTAQUIG®) ADMINISTERED AT MODIFIED DOSING REGIMENS IN PATIENTS WITH PRIMARY IMMUNODEFICIENCY DISEASES","primaryOutcome":{"measure":"IgG Trough Levels From Baseline to End of Study (28 Weeks)","timeFrame":"Through study completion, up to 28 weeks","effectByArm":[{"arm":"Increased Volume Cohort - Cohort 1","deltaMin":0.144,"sd":0.7303},{"arm":"Increased Infusion Rate Cohort - Cohort 2","deltaMin":0.065,"sd":1.1046},{"arm":"Every Other Week Dosing Cohort - Cohort 3","deltaMin":-0.593,"sd":1.0791}],"pValues":[]},"eligibility":{"minAge":"2 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":18,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":15},"commonTop":["Infusion Site Erythema","Infusion Site Pruritis","Sinusitis","Heachache","Infusion Site Pain"]}}